EVE Health Group Limited
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erect… Read more
EVE Health Group Limited (EVE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.242x
Based on the latest financial reports, EVE Health Group Limited (EVE) has a cash flow conversion efficiency ratio of -0.242x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-907.94K) by net assets (AU$3.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EVE Health Group Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how EVE Health Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
EVE Health Group Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EVE Health Group Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Usha Resources Ltd
OTCMKTS:USHAF
|
0.000x |
|
Sanwaria Consumer Limited
NSE:SANWARIA
|
0.000x |
|
Coppermoly Limited
F:5C5
|
-0.042x |
|
UNIV HEALTH SERV-B
BE:UHS
|
0.104x |
|
Millennium Group International Holdings Limited Ordinary Shares
NASDAQ:MGIH
|
-0.051x |
|
Afyren SAS
PA:ALAFY
|
-0.051x |
|
Kafrit
TA:KAFR
|
0.043x |
|
Till Capital Ltd
PINK:TILCF
|
-0.014x |
Annual Cash Flow Conversion Efficiency for EVE Health Group Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of EVE Health Group Limited from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$3.55 Million | AU$-1.62 Million | -0.455x | +49.72% |
| 2024-06-30 | AU$1.22 Million | AU$-1.11 Million | -0.904x | -71.38% |
| 2023-06-30 | AU$3.12 Million | AU$-1.65 Million | -0.528x | +3.00% |
| 2022-06-30 | AU$6.93 Million | AU$-3.77 Million | -0.544x | -146.98% |
| 2021-06-30 | AU$10.19 Million | AU$-2.24 Million | -0.220x | +9.31% |
| 2020-06-30 | AU$12.99 Million | AU$-3.16 Million | -0.243x | -32.63% |
| 2019-06-30 | AU$5.85 Million | AU$-1.07 Million | -0.183x | -67.12% |
| 2018-06-30 | AU$7.38 Million | AU$-808.76K | -0.110x | +45.55% |
| 2017-06-30 | AU$2.78 Million | AU$-558.99K | -0.201x | +45.42% |
| 2016-06-30 | AU$1.75 Million | AU$-645.76K | -0.369x | -305.44% |
| 2015-06-30 | AU$2.64 Million | AU$-240.46K | -0.091x | -368.93% |
| 2014-06-30 | AU$8.11 Million | AU$-157.19K | -0.019x | +79.66% |
| 2013-06-30 | AU$8.18 Million | AU$-779.82K | -0.095x | -39.15% |
| 2012-06-30 | AU$23.04 Million | AU$-1.58 Million | -0.069x | +64.89% |
| 2011-06-30 | AU$25.64 Million | AU$-5.00 Million | -0.195x | -117.47% |
| 2010-06-30 | AU$25.15 Million | AU$-2.26 Million | -0.090x | +29.17% |
| 2009-06-30 | AU$22.93 Million | AU$-2.91 Million | -0.127x | -29.01% |
| 2008-06-30 | AU$25.64 Million | AU$-2.52 Million | -0.098x | -34.67% |
| 2007-06-30 | AU$18.78 Million | AU$-1.37 Million | -0.073x | -104.92% |
| 2006-06-30 | AU$5.98 Million | AU$-212.78K | -0.036x | +46.18% |
| 2005-06-30 | AU$2.22 Million | AU$-146.87K | -0.066x | +70.17% |
| 2004-06-30 | AU$251.35K | AU$-55.71K | -0.222x | -- |